These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19546657)

  • 41. Financial incentives linked to self-assessment of prescribing patterns: a new approach for quality improvement of drug prescribing in primary care.
    Wettermark B; Pehrsson A; Juhasz-Haverinen M; Veg A; Edlert M; Törnwall-Bergendahl G; Almkvist H; Godman B; Granath F; Bergman U
    Qual Prim Care; 2009; 17(3):179-89. PubMed ID: 19622268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. I've been taking vitamin E for several years. It was supposed to help prevent heart disease and cancer. Now I've heard it's not safe. What's going on?
    Mayo Clin Health Lett; 2005 Mar; 23(3):8. PubMed ID: 15812945
    [No Abstract]   [Full Text] [Related]  

  • 43. Prediction of mortality in elderly patients with hip fractures: a two-year prospective study of 1,944 patients.
    Söderqvist A; Ekström W; Ponzer S; Pettersson H; Cederholm T; Dalén N; Hedström M; Tidermark J;
    Gerontology; 2009; 55(5):496-504. PubMed ID: 19628932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infectious disease hospitalizations in the United States.
    Christensen KL; Holman RC; Steiner CA; Sejvar JJ; Stoll BJ; Schonberger LB
    Clin Infect Dis; 2009 Oct; 49(7):1025-35. PubMed ID: 19708796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
    Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
    Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder.
    Laursen TM; Munk-Olsen T; Agerbo E; Gasse C; Mortensen PB
    Arch Gen Psychiatry; 2009 Jul; 66(7):713-20. PubMed ID: 19581562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes mellitus and long-term outcome in heart failure patients after surgical ventricular restoration.
    Castelvecchio S; Ranucci M; Di Donato M; Menicanti L
    Ann Thorac Surg; 2009 Nov; 88(5):1451-6. PubMed ID: 19853091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric nurse practitioners' assessment and management of childhood overweight/obesity: results from 1999 and 2005 cohort surveys.
    Small L; Anderson D; Sidora-Arcoleo K; Gance-Cleveland B
    J Pediatr Health Care; 2009; 23(4):231-41. PubMed ID: 19559991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A dermoscopy survey to assess who is using it and why it is or is not being used.
    Noor O; Nanda A; Rao BK
    Int J Dermatol; 2009 Sep; 48(9):951-2. PubMed ID: 19702978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin E supplementation: what's the harm in that?
    Miller ER; Guallar E
    Clin Trials; 2009 Feb; 6(1):47-9; discussion 50-1. PubMed ID: 19254933
    [No Abstract]   [Full Text] [Related]  

  • 53. Weaknesses of Bayesian model averaging for meta-analysis in the study of vitamin E and mortality.
    Greenland S
    Clin Trials; 2009 Feb; 6(1):42-6; discussion 50-1. PubMed ID: 19254932
    [No Abstract]   [Full Text] [Related]  

  • 54. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole-diet approach, Mediterranean diet, and Alzheimer disease.
    Solfrizzi V; Capurso C; D'Introno A; Colacicco AM; Chirico M; Capurso A; Panza F
    Arch Neurol; 2007 Apr; 64(4):606; author reply 607. PubMed ID: 17420327
    [No Abstract]   [Full Text] [Related]  

  • 57. Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF).
    Ambardekar AV; Fonarow GC; Hernandez AF; Pan W; Yancy CW; Krantz MJ;
    Am Heart J; 2009 Oct; 158(4):644-52. PubMed ID: 19781426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Usage of drugs with potential adverse effects on cognition in a memory-clinic].
    Weih M; Scholz S; Reiss K; Alexopoulos P; Degirmenci U; Richter-Schmidinger T; Kornhuber J
    Fortschr Neurol Psychiatr; 2009 Sep; 77(9):523-7. PubMed ID: 19644785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High doses of vitamin E may increase risk of death. Talk to your doctor before taking supplements containing more than 200 IUs.
    Health News; 2005 Apr; 11(4):12-3. PubMed ID: 15818767
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Thomas S; Holwerda NJ; Cohn JN
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.